Following former President Donald Trump’s executive order, the United States has discontinued funding support for HIV treatment programs in Nigeria and other poor countries. This decision has resulted in a 90-day halt in disbursements from the President’s Emergency Plan for AIDS Relief (PEPFAR), a US effort that provides HIV/AIDS treatment in Africa and other areas.
The decision follows an executive order issued on Trump’s first day in office, which commanded all government departments in charge of foreign development aid to halt funding disbursement. PEPFAR, with an annual budget of $6.5 billion, provides life-saving HIV/AIDS treatment to nearly 20.6 million people worldwide. Since its beginnings, the project is said to have saved 26 million lives, making it a cornerstone of global health efforts.
According to NPR, the suspension of PEPFAR funding could extend at least three months unless the programme is granted an exemption. Public health experts are now raising worries about the program’s possible long-term implications, with some fearing that the Trump administration will completely stop it. Tammy Bruce, a spokesperson for the US State Department, stated that the US “is no longer going to blindly dole out money with no return for the American people.”
This ban will have a severe impact on Nigeria, one of the most HIV-affected countries in the world. With over two million Nigerians living with HIV, PEPFAR has played a key role in providing life-saving medication and strengthening healthcare infrastructure. Over the years, PEPFAR has donated more than $6 billion to Nigeria’s national HIV/AIDS response, saving countless lives and helping to curb the virus’s spread.
